Christopher Horvath

Christopher Horvath, a prolific inventor from Mission Viejo, CA (US), has amassed an impressive portfolio of 80 patents throughout his career. His latest patents aim to treat glaucoma by inventing new ways of using intraocular shunts to relieve intraocular pressure.

Glaucoma is a common affliction that can lead to blindness if not treated properly. It is caused by increased intraocular pressure that damages the optic nerve. One of Horvath's latest patents proposes utilizing an intraocular shunt to reduce intraocular pressure. The shunt is implanted through an entry area below the corneal limbus of an eye and is positioned in the anterior chamber of the eye. An outflow end of the shunt is positioned between layers of Tenon's capsule. This implantation reduces intraocular pressure and provides relief to glaucoma patients.

Horvath's second invention is a manually adjustable intraocular flow regulation mechanism. This invention proposes modifying the flow resistance of the shunt by manually manipulating a portion of the intraocular shunt without surgical intervention. For example, applying pressure along the surface of the eye can displace or separate a portion of the shunt, thereby decreasing the flow resistance of the shunt. This mechanism ensures the relief from high intraocular pressure while avoiding hypotony.

Horvath has worked for notable companies like AqueSys, Inc. and Lensar, Inc. during his career. He also worked with renowned inventors like Laszlo Otto Romoda and Guenther Grabner.

Overall, Christopher Horvath's impressive portfolio of patents and his recent work with intraocular shunts showcase his contributions to innovation in the medical field. His work has the potential to provide relief to millions of people suffering from glaucoma.